Section Arrow
Quote
SRRK.NASDAQ
- Scholar Rock Holding Corp
Quotes are at least 15-min delayed:2026/01/09 20:15 EST
Regular Hours
Last
 42.18
+0.51 (+1.22%)
Day High 
43.62 
Prev. Close
41.67 
1-M High
48.28 
Volume 
948.14K 
Bid
40
Ask
47
Day Low
41.73 
Open
41.74 
1-M Low
41 
Market Cap 
4.25B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 43.72 
20-SMA 44.37 
50-SMA 39.56 
52-W High 48.28 
52-W Low 22.71 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.15/-2.39
Enterprise Value
4.31B
Balance Sheet
Book Value Per Share
2.40
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
MREOMereo BioPharma Group plc0.4944+0.11+28.62%-- 
ASBPAspire Biopharma Holdings Inc.0.104+0.0007+0.68%-- 
RVMDRevolution Medicines118.64+11.25+10.48%-- 
ARDXArdelyx7.74+0.74+10.57%-- 
SLSSELLAS Life Sciences Group3.46-0.4-10.36%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.